Riskpilot← Back to searchSign inGet full accessNYMARK INVEST AS
ASActiveOrg 989145088Vågsgata 1, 6090 FosnavågRetail sale of medical and orthopaedic goods · NACE 4774Est. 20060 employees
Revenue 2024
NOK 0
EBITDA margin
—
+20% vs 2023
Equity ratio
91.7%
Financial strength
Net profit 2024
NOK 406K
+35% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -36K | +20% |
| Net profit | NOK 406K | +35% |
| Total assets | NOK 5,6M | +8% |
| Equity | NOK 5,1M | +9% |
| Employees | 0 | — |
Legal name
NYMARK INVEST AS
Org number
989145088
Legal form
Aksjeselskap
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
5. januar 2006
Share capital
NOK 432 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Kjøp, sal og forvaltning av aksjar og dessutan utøve dei funksjonane som normalt ligg under rolla som holdingselskap.
Address
Vågsgata 1, 6090 Fosnavåg
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −41 | −61 | −50 | −45 | −36 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −41 | −61 | −50 | −45 | −36 |
| Net financials | 754 | 507 | 246 | 345 | 442 |
| Profit before tax | 713 | 445 | 196 | 300 | 406 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 713 | 445 | 196 | 300 | 406 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 5 734 | 5 270 | 4 866 | 5 166 | 5 572 |
| Equity | 5 673 | 4 209 | 4 404 | 4 704 | 5 111 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 61 | 1 061 | 461 | 461 | 461 |
| Total debt | 61 | 1 061 | 461 | 461 | 461 |
EBITDA margin
-3572600.0%
This company
15.8%
Market median
-22611492% vs market
20202024
Equity ratio
91.7%
This company
38.2%
Market median
+140% vs market
20202024
Return on equity
7.9%
This company
18.4%
Market median
-57% vs market
20202024
Net profit margin
40626700.0%
This company
8.1%
Market median
+501564098% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.09×
This company
0.62×
Market median
+85% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JA Chief Executive Officer | Chief Executive Officer | 2026 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2013 | |
| Chairman | 2013 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
NYMARK INVEST AS 
Abr Nymark AsBoard members of NYMARK INVEST AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| John Abraham Nymark | Chief Executive Officer | 0 companies |
| Gitte Nymark | Board of Directors | 0 companies |
| Inge Kristian Hansen | Chairman | 0 companies |